BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26643855)

  • 1. Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors.
    Kamp K; Alwani RA; Korpershoek E; Franssen GJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2016 Mar; 174(3):271-80. PubMed ID: 26643855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up.
    Kamp K; Feelders RA; van Adrichem RC; de Rijke YB; van Nederveen FH; Kwekkeboom DJ; de Herder WW
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3060-9. PubMed ID: 24905065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and relevance of adrenal masses in patients with sporadic gastroenteropancreatic neuroendocrine tumours (GEP-NET).
    Kanakis G; Kamp K; Tsiveriotis K; Feelders RA; Zormpala A; de Herder WW; Kaltsas G
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):950-6. PubMed ID: 22970733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in India: A report of multicenter data from a web-based registry.
    Palepu J; Shrikhande SV; Bhaduri D; Shah RC; Sirohi B; Chhabra V; Dhar P; Sastry R; Sikora S
    Indian J Gastroenterol; 2017 Nov; 36(6):445-451. PubMed ID: 29457213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors].
    Yang XO; Li JN; Qian JM; Yang H; Chen Q; Lu L
    Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):124-7. PubMed ID: 21418832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
    Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
    Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients.
    de Laat JM; Pieterman CR; van den Broek MF; Twisk JW; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3325-33. PubMed ID: 24915123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis.
    Chan DT; Luk AO; So WY; Kong AP; Chow FC; Ma RC; Lo AW
    BMC Endocr Disord; 2016 Feb; 16():12. PubMed ID: 26911576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.
    Isidori AM; Kaltsas GA; Pozza C; Frajese V; Newell-Price J; Reznek RH; Jenkins PJ; Monson JP; Grossman AB; Besser GM
    J Clin Endocrinol Metab; 2006 Feb; 91(2):371-7. PubMed ID: 16303835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France.
    Lombard-Bohas C; Mitry E; O'Toole D; Louvet C; Pillon D; Cadiot G; Borson-Chazot F; Aparicio T; Ducreux M; Lecomte T; Etienne PL; Cacheux W; Legoux JL; Seitz JF; Ruszniewski P; Chayvialle JA; Rougier P;
    Neuroendocrinology; 2009; 89(2):217-22. PubMed ID: 18719344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
    Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M
    Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
    Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
    Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic ACTH syndrome caused by desmopressin-responsive thymic neuroendocrine tumor.
    Sekiguchi Y; Miyamoto Y; Kasahara I; Hara Y; Tani Y; Doi M; Hirata Y
    Endocr J; 2015; 62(5):441-7. PubMed ID: 25819222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.
    Ito T; Sasano H; Tanaka M; Osamura RY; Sasaki I; Kimura W; Takano K; Obara T; Ishibashi M; Nakao K; Doi R; Shimatsu A; Nishida T; Komoto I; Hirata Y; Nakamura K; Igarashi H; Jensen RT; Wiedenmann B; Imamura M
    J Gastroenterol; 2010 Feb; 45(2):234-43. PubMed ID: 20058030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
    Ito T; Igarashi H; Nakamura K; Sasano H; Okusaka T; Takano K; Komoto I; Tanaka M; Imamura M; Jensen RT; Takayanagi R; Shimatsu A
    J Gastroenterol; 2015 Jan; 50(1):58-64. PubMed ID: 24499825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years.
    Neary NM; Lopez-Chavez A; Abel BS; Boyce AM; Schaub N; Kwong K; Stratakis CA; Moran CA; Giaccone G; Nieman LK
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2223-30. PubMed ID: 22508705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance.
    Daskalakis K; Tsoli M; Srirajaskanthan R; Chatzellis E; Alexandraki K; Angelousi A; Pizanias M; Randeva H; Kaltsas G; Weickert MO
    Neuroendocrinology; 2019; 108(4):308-316. PubMed ID: 30673674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience.
    Ejaz S; Vassilopoulou-Sellin R; Busaidy NL; Hu MI; Waguespack SG; Jimenez C; Ying AK; Cabanillas M; Abbara M; Habra MA
    Cancer; 2011 Oct; 117(19):4381-9. PubMed ID: 21412758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole exome sequencing of thymic neuroendocrine tumor with ectopic ACTH syndrome.
    Li Y; Peng Y; Jiang X; Cheng Y; Zhou W; Su T; Xie J; Zhong X; Song D; Wu L; Fan L; Li M; Hong J; Wang W; Ning G; Cao Y
    Eur J Endocrinol; 2017 Feb; 176(2):187-194. PubMed ID: 27913610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.